Cadrenal Therapeutics, Inc. (CVKD) stock
CVKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.72−0.16 (-8.51%)
Close on Nov 18, 2026Market cap $6.14MP/E –Yield 959.30%
Cadrenal Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Cadrenal Therapeutics's market cap was $4.49M on Nov 11, 2026, against $19.34M a year earlier. Over the last 4 years it ranged from $3.05M to $33.87M, with a median of $13.97M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $4.49M | -67.8% |
| 2025 | Dec 31, 2025 | $13.97M | -21.9% |
| 2024 | Dec 31, 2024 | $17.89M | +85.7% |
| 2023 | Dec 29, 2023 | $9.64M | – |
See a number that looks wrong?